These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1450364)

  • 1. Effect of vitamin B6 supplementation on plasma oxalate and oxalate removal rate in hemodialysis patients.
    Costello JF; Sadovnic MC; Smith M; Stolarski C
    J Am Soc Nephrol; 1992 Oct; 3(4):1018-24. PubMed ID: 1450364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
    Costello JF; Sadovnic MJ; Cottington EM
    J Am Soc Nephrol; 1991 Jun; 1(12):1289-98. PubMed ID: 1912391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pyridoxine supplementation on plasma oxalate concentrations in patients receiving dialysis.
    Tomson CR; Channon SM; Parkinson IS; Sheldon WS; Ward MK; Laker MK
    Eur J Clin Invest; 1989 Apr; 19(2):201-5. PubMed ID: 2499479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients.
    Shah GM; Ross EA; Sabo A; Pichon M; Reynolds RD; Bhagavan H
    Am J Kidney Dis; 1992 Jul; 20(1):42-9. PubMed ID: 1621677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases.
    Lorenz EC; Lieske JC; Seide BM; Olson JB; Mehta R; Milliner DS
    Am J Kidney Dis; 2021 May; 77(5):816-819. PubMed ID: 32891627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of erythrocyte oxalate flux rate and urinary oxalate excretion in hyperoxaluric rats.
    Kaul P; Sidhu H; Sharma SK; Thind SK; Nath R
    Biochem Mol Biol Int; 1993 Sep; 31(1):83-93. PubMed ID: 8260949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitamin B6-deficiency and -substitution in chronic uremia (author's transl)].
    Gäng V; Schulz RJ; Kult J; Heidland A
    Klin Wochenschr; 1975 Apr; 53(7):335-8. PubMed ID: 1052689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary hyperoxalemia in chronic renal failure.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Int J Artif Organs; 1982 May; 5(3):141-3. PubMed ID: 7107047
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients.
    Ono K
    Clin Nephrol; 1986 Nov; 26(5):239-43. PubMed ID: 3802587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily requirement for pyridoxine supplements in chronic renal failure.
    Kopple JD; Mercurio K; Blumenkrantz MJ; Jones MR; Tallos J; Roberts C; Card B; Saltzman R; Casciato DA; Swendseid ME
    Kidney Int; 1981 May; 19(5):694-704. PubMed ID: 7289398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis.
    Chiang EP; Selhub J; Bagley PJ; Dallal G; Roubenoff R
    Arthritis Res Ther; 2005; 7(6):R1404-11. PubMed ID: 16277693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
    Plumb TJ; Swee ML; Fillaus JA
    Am J Kidney Dis; 2013 Dec; 62(6):1155-9. PubMed ID: 23830800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin B6 administration on elevated plasma oxalic acid levels in haemodialysed patients.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Eur J Clin Invest; 1982 Dec; 12(6):481-3. PubMed ID: 6818036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Calcium and Vitamin B6 Supplementation on Oxalate Excretion in a Rodent Gastric Bypass Model of Enteric Hyperoxaluria.
    Espino-Grosso P; Monsour C; Canales BK
    Urology; 2019 Feb; 124():310.e9-310.e14. PubMed ID: 30412704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pyridoxine supplementation on recurrent stone formers.
    Murthy MS; Farooqui S; Talwar HS; Thind SK; Nath R; Rajendran L; Bapna BC
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):434-7. PubMed ID: 7141762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of elevated plasma oxalic acid by pyridoxine therapy in patients on RDT.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H
    Proc Eur Dial Transplant Assoc; 1983; 19():308-12. PubMed ID: 6878246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.
    Tang X; Voskoboev NV; Wannarka SL; Olson JB; Milliner DS; Lieske JC
    Am J Nephrol; 2014; 39(5):376-82. PubMed ID: 24776840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria.
    Kaelin A; Casez JP; Jaeger P
    Urol Res; 2004 Feb; 32(1):61-8. PubMed ID: 14628106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.